Principal Street Partners’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.72M | Buy |
3,871
+1,535
| +66% | +$683K | 0.17% | 83 |
|
|
2025
Q1 | $1.13M | Buy |
2,336
+78
| +3% | +$37.8K | 0.21% | 69 |
|
|
2024
Q4 | $909K | Sell |
2,258
-752
| -25% | -$303K | 0.18% | 74 |
|
|
2024
Q3 | $1.41M | Buy |
3,010
+629
| +26% | +$294K | 0.23% | 71 |
|
|
2024
Q2 | $1.12M | Sell |
2,381
-29
| -1% | -$13.6K | 0.2% | 69 |
|
|
2024
Q1 | $1.01M | Buy |
2,410
+177
| +8% | +$74.3K | 0.19% | 71 |
|
|
2023
Q4 | $909K | Sell |
2,233
-102
| -4% | -$41.5K | 0.22% | 73 |
|
|
2023
Q3 | $812K | Sell |
2,335
-117
| -5% | -$40.7K | 0.16% | 97 |
|
|
2023
Q2 | $863K | Sell |
2,452
-28
| -1% | -$9.85K | 0.21% | 77 |
|
|
2023
Q1 | $781K | Sell |
2,480
-974
| -28% | -$307K | 0.2% | 77 |
|
|
2022
Q4 | $997K | Sell |
3,454
-291
| -8% | -$84K | 0.25% | 66 |
|
|
2022
Q3 | $1.09M | Buy |
3,745
+153
| +4% | +$44.3K | 0.29% | 64 |
|
|
2022
Q2 | $1.01M | Sell |
3,592
-479
| -12% | -$135K | 0.26% | 66 |
|
|
2022
Q1 | $1.06M | Sell |
4,071
-351
| -8% | -$91.7K | 0.24% | 71 |
|
|
2021
Q4 | $971K | Buy |
4,422
+1,603
| +57% | +$352K | 0.23% | 75 |
|
|
2021
Q3 | $512K | Sell |
2,819
-1,463
| -34% | -$266K | 0.14% | 117 |
|
|
2021
Q2 | $864K | Sell |
4,282
-4,783
| -53% | -$965K | 0.23% | 87 |
|
|
2021
Q1 | $1.95M | Buy |
9,065
+4,631
| +104% | +$995K | 0.25% | 77 |
|
|
2020
Q4 | $1.05M | Buy |
4,434
+229
| +5% | +$54.1K | 0.32% | 71 |
|
|
2020
Q3 | $1.14M | Sell |
4,205
-150
| -3% | -$40.8K | 0.4% | 67 |
|
|
2020
Q2 | $1.26M | Buy |
4,355
+134
| +3% | +$38.9K | 0.47% | 57 |
|
|
2020
Q1 | $1M | Sell |
4,221
-1,005
| -19% | -$239K | 0.42% | 49 |
|
|
2019
Q4 | $1.14M | Sell |
5,226
-1,691
| -24% | -$370K | 0.25% | 68 |
|
|
2019
Q3 | $1.16M | Buy |
6,917
+2,928
| +73% | +$493K | 0.29% | 61 |
|
|
2019
Q2 | $732K | Buy |
3,989
+434
| +12% | +$79.6K | 0.4% | 74 |
|
|
2019
Q1 | $654K | Buy |
+3,555
| New | +$654K | 0.28% | 52 |
|